Edward Merle Johnson II, PharmD, PhD, MBA, BCPS
Edward Merle Johnson II, PharmD, PhD, MBA, BCPS received his PharmD from West Virginia University School of Pharmacy in 2003 and his PhD in Organic Chemistry/Drug Design and Synthesis from University of Wisconsin – Milwaukee in 2012. Afterwards, Dr Johnson continued his education and received an MBA in Healthcare Administration from Concordia University – Wisconsin in 2016 and obtained Lean Six Sigma Black Belt certification in 2018. Dr Johnson has obtained multiple clinical and professional certifications including Board Certified Pharmacotherapy Specialist, pharmacogenomic certification, and pain management certification. In addition, Dr Johnson has authored numerous patents for investigative drugs used to treat CNS disorder, along with organic chemistry synthetic papers, and organizational white papers for clinical guidelines, protocols, and certified medical education (CME). He has been an honored guest presenter/lecturer at multiple regional medical centers and university across the country to delivery information relating to pharmacogenomics, drug design, and applying chemistry to pharmacy practice. Dr Johnson is an experienced pharmacy leader and researcher with a demonstrated history of working in clinical hospitals, healthcare industries, academic research, and pharmaceutical startup companies. He is skilled in CNS disorders focusing on drug therapies and drug design and development, synthetic organic chemistry, drug metabolism, and pharmacogenomics and precision medicine. Dr Johnson is a co-founder and managing member of Algin Scientific pharmacy and pharmaceutical consulting company.
Teaching Areas and Interests
Dr. Johnson enjoys teaching students about the importance of chemistry (organic/medicinal chemistry) in everyday pharmacy practice. He specializes in teaching students about pharmacophores, drug metabolism, drug design and development (prodrugs and bioisosteres), and how these factors influence pharmacodynamics (PD) and pharmacokinetics (PK/ADME). He also has a passion for genetics and pharmacogenomics and its implementation into healthcare and pharmacy practice. Dr. Johnson is extremely pro-pharmacy and encourages students to learn and become beacons of knowledge within their organization to further support pharmacist’s value and improve patient’s outcomes.
Professional Activities and Awards
Dr. Edward Johnson enjoys being a member within the pharmacy community and taking part in multiple learned or honored societies such as American College of Clinical Pharmacy (ACCP), Pharmacogene Variation Consortium (PharmVar), Clinical Pharmacogenetics Implementation Consortium (CPIC), American Society of Health-System Pharmacists (ASHP), Pharmacy Society of Wisconsin (PSW), Phi Lambda Sigma Pharmacy Leadership Society, Rho Chi Pharmacy Fraternity (Chapter President 2001 – 2002). In addition, Dr. Johnson has been recognized as an outstanding clinical instructor and preceptor for the Concordia University Wisconsin, School of Pharmacy, Mequon WI and the University of Tennessee Health Science Center, College of Pharmacy, Memphis TN.
Dr. Johnson currently spends the majority of his time studying and mapping drug metabolism pathways for both human and non-human patients, pharmacogenomic adaptations and implications to healthcare and pharmacy practice, developing clinical pharmacy guidelines involving pain management, anticoagulation, and behavior health medications used for CNS disorders.